Latest On-Demand Webinars & Online Events

This webinar explores a highly sensitive, automated assay workflow to provide high-quality results for low-abundance biomarkers in serum, plasma and cerebrospinal fluid.

This webinar explores how non-invasive proteomic biomarkers enable personalized treatment and deeper disease insights. Plus, learn about a platform that measures 11,000 proteins to accelerate biomarker discovery.

Join this webinar to learn the fundamentals of spatial multiplexing for single-cell proteomics and hear how it enables the in-depth exploration of complex tissue microenvironments through the detection and quantification of a virtually unlimited number of protein target analytes.

Meaningful biomarker studies that account for genetic, environmental and lifestyle variation, or comprise of complex signatures from multiple proteins, require large cohorts – too large for the current proteomics discovery platforms.

Alzheimer’s disease (AD) is the most common form of dementia in the elderly population. While several peptide and protein biomarkers in cerebrospinal fluid (CSF) have been used for AD diagnosis, an unequivocal diagnosis in the early phases of AD is still lacking.

To ensure the safety and efficacy of LNP-based drugs, comprehensive characterization of these sophisticated molecules–the lipids and the genetic cargo–is paramount.

Unearthing novel drug targets with robust data support and a deep understanding of biological processes remains a pivotal challenge in drug discovery. In this engaging webinar, distinguished speakers Aaron Mitchell and Rasmus Wernersson from ZS Associates will unveil a comprehensive method that significantly enhances target prediction performance through the integration of multiomics data, coupled with a data-driven, cell-type specific network biology approach.

In this webinar, you’ll hear how automated liquid handling for LC-MS/MS sample preparation contributed to the identification and quantification of over 30 metabolites that can predict adverse pregnancy outcomes, including pre-eclampsia.

In this webinar, our speaker will discuss the role of glucosyl and galactosyl ceramides as biomarkers and how their misregulation can be an identifier for various disease states including, but not limited to, Parkinson’s, Krabbe and Gaucher diseases.

This webinar highlights a platform that can identify biomarkers with clinical benefit in non-small cell lung cancer and analyze the immune microenvironment in bone marrow trephine samples.